1. Introduction {#sec0005}
===============

Liposarcoma is one of the most common soft tissue sarcomas. It accounts for approximately 10% of all soft tissue sarcomas, and its peak incidence occurs around the fifth to sixth decades of life \[[@bib0005]\]. Intra-abdominal liposarcoma, including omental sarcoma, is rare \[[@bib0010]\]. We herein report a surgical case of liposarcoma of the greater omentum along with a review of the literature. It is reported in line with the PROCESS criteria \[[@bib0015]\].

2. Presentation of case {#sec0010}
=======================

A 60-year-old woman underwent screening blood tests, which revealed a high serum amylase level. Computed tomography (CT) showed an 8- × 8- × 4-cm abdominal mass on the cranial side of the bladder, an intra-abdominal lipoma was suspected and observed ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Abdominal CT showed an 8 × 8 × 4 cm mass (arrowhead) on the cranial side of the bladder in the abdomen.Fig. 1

Three years later, she underwent a medical examination, and an elastic hard mass with slight tenderness was palpated in the abdomen. She had no abdominal pain, nausea, constipation, or other symptoms. Contrast-enhanced CT and magnetic resonance imaging (MRI) showed a large, well-defined abdominal mass with low attenuation and fat density measuring 20 × 17 × 7 cm. The mass was adjacent to another abnormal region measuring 6 × 6 × 5 cm with septae and a capsule. Contrast-enhanced CT also revealed omental artery involvement in the mass, and an omental tumor was suspected. MRI showed no evidence of invasion to other organs, including the digestive tract, bladder, or great vessels. A liposarcoma (smaller region) with a lipoma (larger mass) was suspected, and no metastatic lesions were observed ([Fig. 2](#fig0010){ref-type="fig"}a, b). After the conference of the surgeons and physicians, confirming the possibility of the tumor resection being with other structures in case of invasion, the patient consented the plan for the surgery and surgical resection was performed.Fig. 2(a) T2-weighted MRI showed a large, well-defined, low-signal mass measuring 20 × 17 × 7 cm (arrowhead) in the abdomen. (b) The mass was adjacent to another abnormal region measuring 6 × 6 × 5 cm with septae and a capsule (arrow).Fig. 2

Intraoperatively, 20 cm midline incision of the abdominal wall was made. A huge, yellowish soft mass with a dark reddish-gray region adjacent to the mass was found under the abdominal wall without invasion, including colon, intestine, mesentery, abdominal wall, bladder, uterus, and retroperitoneum. After ligation of the feeder vessel originating from the omental artery, existing cranial side of the mass, the mass was resected en bloc ([Fig. 3](#fig0015){ref-type="fig"}a, b). No evidence of intra-abdominal metastasis was found. The surface of the mass was carefully treated and not raptured.Fig. 3(a) A huge yellowish, soft mass with a dark reddish-gray region adjacent to the mass was located under the abdominal wall. (b) The feeder vessel originated from the omental artery.Fig. 3

The resected specimen, which comprised a yellowish mass and reddish-gray region, weighed 3750 g and measured 27 × 20 × 10 cm ([Fig. 4](#fig0020){ref-type="fig"}a, b). Histopathological examination showed that within the reddish-gray region (black arrowhead in [Fig. 4](#fig0020){ref-type="fig"}b), neoplastic spindle cells with atypical nuclei containing condensed chromosomes were present in the septae ([Fig. 5](#fig0025){ref-type="fig"}a). Lipoblasts and inflammatory cells were present. Necrosis of fat was also observed. Near the reddish-gray region in the yellowish mass (black arrow in [Fig. 4](#fig0020){ref-type="fig"}b), malignant cells were also seen ([Fig. 5](#fig0025){ref-type="fig"}b). Far from the reddish-gray region in the yellowish mass (white arrow in [Fig. 4](#fig0020){ref-type="fig"}b), mature adipocytes with uniform nuclei resembling normal fat tissue were observed ([Fig. 5](#fig0025){ref-type="fig"}c). Immunohistochemical analysis revealed the MDM2+/CDK4+ immunophenotype (black arrowhead and black arrow in [Fig. 4](#fig0020){ref-type="fig"}b) and the MDM2−/CDK4− immunophenotype (white arrow in [Fig. 4](#fig0020){ref-type="fig"}b).Fig. 4(a) The resected specimen, including the yellowish mass (yellow arrowhead) and reddish-gray region (red arrowhead), weighed 3750 g and measured 27 × 20 × 10 cm. (b) The cut surface of the tumor was shown. The diagnosis was a well-differentiated liposarcoma in the areas of black arrow and black arrowhead, and a lipoma in the area of white arrow.Fig. 4Fig. 5(a) Neoplastic spindle cells with atypical nuclei containing condensed chromosomes were present in the septae in the reddish-gray region (black arrowhead in [Fig. 4](#fig0020){ref-type="fig"}b). (b) Malignant cells were also seen in the area near the reddish-gray region in the yellowish mass (black arrow in [Fig. 4](#fig0020){ref-type="fig"}b). (c) The area far from the reddish-gray region in the yellowish mass (white arrow in [Fig. 4](#fig0020){ref-type="fig"}b) was composed of mature adipocytes with uniform nuclei resembling normal fat tissue.Fig. 5

The diagnosis was a well-differentiated liposarcoma (black arrow and black arrowhead in [Fig. 4](#fig0020){ref-type="fig"}b) and a lipoma (white arrow in [Fig. 4](#fig0020){ref-type="fig"}b) based on the histopathological features. The resected margin was microscopically negative (R0).

The patient had an uneventful postoperative period. No recurrence or significant problems had occurred at 9 months postoperatively.

3. Discussion {#sec0015}
=============

Liposarcomas are usually located in the gluteal region, thighs, popliteal fossa, shins, and retroperitoneum \[[@bib0020]\]. Intra-abdominal liposarcoma is uncommon \[[@bib0010]\]. In addition to the greater omentum, liposarcomas have been reported in the small bowel \[[@bib0025]\], small bowel mesentery \[[@bib0030]\], colon \[[@bib0035]\], and mesorectum \[[@bib0040]\]. Omental metastatic and recurrent tumors are common, but primary tumors are relatively rare \[[@bib0045]\]. Primary tumors of the greater omentum have various histological differential diagnoses including liposarcoma, lipoma, mesothelioma, hemangiopericytoma, stromal tumor, leiomyoma, neurofibroma, fibroma, fibrosarcoma, and leiomyosarcoma \[[@bib0050]\].

The prognosis of a liposarcoma in the trunk, including the intra-abdominal region, retroperitoneum, and thoracic cavity, is worse than that of a liposarcoma in the extremities. In one study, the median 5-year disease-free survival rates for liposarcomas in the trunk vs. extremities were 41.9% vs. 66.7% (P \< 0.001), and the 5-year overall survival rates were 64.5% vs. 84.5% (P \< 0.001), respectively \[[@bib0055]\]. The prognosis of these tumors also depends on the histological subtype. The 5-year disease-free survival rate is worse for dedifferentiated, round cell, and pleomorphic liposarcomas (high-grade group) than for well-differentiated and myxoid types (low-grade group) (16.9% vs. 65.7%, P \< 0.001); the 5-year overall survival rate is also worse (47.8% vs. 83.5%, P \< 0.001) \[[@bib0055],[@bib0060]\].

Primary omental liposarcoma is rare, and De et al. \[[@bib0065]\] reviewed nine cases from 1936 to 2003. Since that review, 10 cases were reported in the English-language literature from 2003 to 2018, including our case. These 19 cases were reviewed in the present study ([Table 1](#tbl0005){ref-type="table"}). The average age of the patients was 51.1 years (range, 11--83 years). Although our patient was asymptomatic, the patients in previous reports exhibited various symptoms including abdominal pain, swelling, fever \[[@bib0065]\], constipation \[[@bib0070]\], and abdominal distention \[[@bib0075]\]. Cases of liposarcoma of the greater omentum presenting as inguinal hernia and torsion have also been reported \[[@bib0080]\]. Our patient developed ischemic change in the reddish-gray, elastic hard region of the mass. We considered that this ischemic mass may have developed by torsion; nevertheless, the patient had no episodes of acute abdominal pain. Complete tumor resection is recommended for greater omental liposarcoma \[[@bib0080]\]. Our review showed that the tumors in 15 patients (78.9%) were resectable and that wide tumor resection was needed for 4 patients (26.7%). In terms of histologic subtypes, three tumors (15.8%) were well-differentiated, five (26.3%) were myxoid, three (15.8%) were pleomorphic, four (21.1%) were round cell, one (5.3%) was dedifferentiated, and three (15.8%) were not classified. Although our review of these 19 cases included a long-term survivor (13 years) with myxoid liposarcoma, 6 patients died during the follow-up period. A recent study suggested that postoperative radiation therapy may improve outcomes in patients with retroperitoneal liposarcoma, especially for subtypes other than well-differentiated tumors \[[@bib0085]\]. Because of the risk of radiation enteritis and the rarity of the disease, adjuvant radiation for omental liposarcoma remains controversial. Although adjuvant chemotherapy also remains controversial, chemotherapy seems promising in the treatment of liposarcoma \[[@bib0090], [@bib0095], [@bib0100]\].Table 1The characteristics of the reported cases of a liposarcoma of the greater omentum.Table 1ReferenceNo.Author/yearAge/SexMain clinical presentationPreoperative imagingOperationTorsionWeight (g)Size(cm)Histological subtypeAdjuvant therapyFollow- upOutcome\[[@bib0135]\]1Manne et al/193640/MAbdominal swellingUnknownRepeated paracentesisUnknownUnknownUnknownNot classifiedUnknown9 monthDead\[[@bib0140]\]2Robb/196034/MEpigastric painUnknownResection (details unknown)UnknownUnknownUnknownNot classifiedUnknown6 monthNo recurrence\[[@bib0145]\]3Stout et al/196360/FAbdominal pain and swellingUnknownLaparotomy and biopsyUnknownUnknownUnknownMyxoidUnknown2 daysDead\[[@bib0150]\]4McAvoy et al/197865/MAbdominal distensionUnknownResection (details unknown)UnknownUnknownUnknownNot classifiedYesNot mentionedNot mentioned\[[@bib0155]\]5Kadow et al/198936/MAbdominal distension and dyspepsiaUSSimple tumor resectionNoUnknown25 × 19 × 15PleomorphicRadiation + CPA + VCR + ADM + dacarbazine3 monthsLocal recurrance\[[@bib0155]\]6Kadow et al/198971/MRetrosternal discomfort, lethargy, weight loss, night sweatsUnknownSimple tumor resectionNoUnknown28 × 18 × 12PleomorphicNoNot mentionedNot mentioned\[[@bib0015]\]7Okajima et al/199354/FAbdominal swelling, leg edemaUS, CT, angipographySimple tumor resectionUnknown2,30027 × 17 × 11Round cellNo10 monthsNo recurrence\[[@bib0075]\]8Tsutsumi et al/199983/MAbdominal pain and distentionUS, CT, angipographySimple tumor resectionYes64018 × 10 × 7Round cellNo2 yearsNo recurrence\[[@bib0060]\]9De et al/200345/MAbdominal pain and distention, feverUS, CTSimple tumor resectionNo95015 × 10 × 2, with smallnodulesRound cellNo9 monthsDead\[[@bib0160]\]10Alameda et al/200325/FAbdominal distentionCTWide tumor resection with epiploic appendicesNo2,10024 × 24 × 4Round cellNo1 yearSurvival with no information of recurrance\[[@bib0165]\]11Milic et al/200450/FAbdominal distension and costipationNot mentionedSimple tumor resectionNo1,90022 × 12 × 7MyxoidNo13 yearsDead (Peritoneal dissemination)\[[@bib0010]\]12Milic et al/200552/MLeft abdominal and groin painNot mentionedSimple tumor resectionNo1,40017 × 11 × 7MyxoidNo3.5 yearsNo recurrence\[[@bib0170]\]13Imai et al/200655/FWeight loss and abdominal distensionUS, CTVolume reduction surgeryNo5,900Over 15 cm (US)MyxoidNo1 monthDead (Progress of primary tumor)\[[@bib0100]\]14Meloni et al/200934/MAbdominal distensionUS, CT, MRIResection (details unknown)NoUnknown25 × 13 (CT)Well- differentiatedNo5 yearsNo recurrence\[[@bib0070]\]15Soufi et al/201265/FAbdominal pain and distension, constipationCTWide tumor resection with omentectomy, appendectomyNoUnknown30 × 27 × 19 (CT)DedifferentiatedDoxorubicin8 monthsNo recurrence\[[@bib0175]\]16Tomita et al/201263/MAbdominal discomfort and feverCTNoneNoUnknownNot mentionedPleomorphicNo2.5 monthsDead (Lung congestion and pneumonia)\[[@bib0065]\]17Hightower et al/201411/MAbdominal painUS, CTWide tumor resection with appendectomyNo4,50021 × 8×8 (CT)MyxoidNo6 monthsLung metastases\[[@bib0085]\]18Rajshekher/201565/FAbdominal pain and distension, decreased appetiteUS, CTWide tumor resection with omentectomy, wedge resection of stomachNo7,50023 × 20 × 12Well- differentiatedDoxorubicin3 yearsNo recurrence　19Our case/201863/FWithout symptoms (health check)CT, MRISimple tumor resectionYes3,75027 × 20 × 10Well- differentiatedNo9 monthsNo recurrence[^1][^2][^3][^4][^5][^6]

Liposarcoma often has different histological components including both benign and malignant areas \[[@bib0105],[@bib0110]\]. The tumor in the present case had two sections: a reddish-gray area with ischemic change and a huge, soft fatty yellowish mass. Liposarcoma was diagnosed in the reddish-gray area, and the near side of the fatty yellowish mass was formed by lipoblasts. Mature fat cells were observed in the far side of the yellowish mass, and this region was diagnosed as lipoma. A recent study suggested biologic potency of transformation of benign lipoma into well-differentiated liposarcoma \[[@bib0115],[@bib0120]\]. Nevertheless, the pathogenetic concept of liposarcoma arising from benign lipoma is generally not accepted \[[@bib0120],[@bib0125]\].

The CT and MRI appearances of a well-differentiated liposarcoma are similar to those of normal fat and other abdominal tumors \[[@bib0105]\]. A well-differentiated liposarcoma is characterized by a lesion size of \>10 cm, the presence of thick septa, the presence of globular and/or nodular non-adipose areas or masses, and a lesion component of \<75% fat \[[@bib0130]\]. Resection should be considered for huge intra-abdominal lipomatous tumors.

4. Conclusion {#sec0020}
=============

Liposarcoma of the greater omentum is rare, and 19 cases were reviewed. Differentiation of liposarcoma from other tumors is challenging. Adjuvant therapy has not been established as an effective therapy, and radical resection of the tumor is recommended.

Funding {#sec0025}
=======

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Ethical approval {#sec0030}
================

This is a case report and it did not require ethical approval from ethics committee. We have got permission from the patient to publish.

Consent {#sec0035}
=======

Written consent to publish this case report was obtained from the patient.

Author contribution {#sec0040}
===================

Shintaro Hashimoto, Junichi Arai, and Hidetoshi Fukuoka were responsible for the study concept and performed the operation. Masato Nishimuta, Hirofumi Matsumoto, Masashi Muraoka, Masahiro Nakashima, and Hiroyuki Yamaguchi collaborated in the patient's medical care. Hiroyuki Yamaguchi reviewed the manuscript. All authors approved the final article.

Registration of research studies {#sec0045}
================================

Not Applicable.

Guarantor {#sec0050}
=========

Junichi Arai.

Provenance and peer review {#sec0055}
==========================

Not commissioned, externally peer-reviewed.

Declaration of Competing Interest {#sec0060}
=================================

None.

[^1]: US: Ultra sonography.

[^2]: CT: Computed tomography.

[^3]: MRI: Magnetic Resonance Imaging.

[^4]: CPA: Cyclophosphamide.

[^5]: VCR: Vincristine.

[^6]: ADM: Adriamycin.
